SOM.AX · SOMNOMED LIMITED
Australia · RS rating 5 · As of 2026-10-14
| Price | 0.27 AUD |
|---|---|
| 1-day change | +3.9% |
| RS rating (overall / 1M / 3M / 12M) | 5 / 14 / 6 / 10 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 11 / 28 |
| Industry group (rank) | Medical-Biomed/Biotech (–) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +69.7% |
| Market cap (USD) | $42.1M |